Dr Reddy’s Laboratories, along with its subsidiaries, announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, on Thursday. The store brand is equivalent to Pataday Once Daily Relief and Pataday Twice Daily Relief in the US market.